Assessment of immunologic competence and host reactivity against tumor antigens in breast cancer patients. Prognostic value and rationale of immunotherapy development.
Head
J F
JF
Elliott Mastology Center, Baton Rouge, Louisiana 70816.
Wang
F
F
Elliott
R L
RL
McCoy
J L
JL
D000951:Antigens, Neoplasm / Q000276:immunology*; D001943:Breast Neoplasms / Q000188:drug therapy / Q000276:immunology*; D006801:Humans; D008213:Lymphocyte Activation; D016019:Survival Analysis
D000951:Antigens, Neoplasm